SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-16-529513
Filing Date
2016-04-04
Accepted
2016-04-04 16:58:40
Documents
82
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d128079d10k.htm 10-K 1369229
2 EX-10.7.4 d128079dex1074.htm EX-10.7.4 39847
3 EX-31.1 d128079dex311.htm EX-31.1 5860
4 EX-31.2 d128079dex312.htm EX-31.2 5884
5 EX-32.1 d128079dex321.htm EX-32.1 4413
  Complete submission text file 0001193125-16-529513.txt   6638680

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bgmd-20151231.xml EX-101.INS 1065384
7 XBRL TAXONOMY EXTENSION SCHEMA bgmd-20151231.xsd EX-101.SCH 66597
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bgmd-20151231_cal.xml EX-101.CAL 78388
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bgmd-20151231_def.xml EX-101.DEF 435927
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE bgmd-20151231_lab.xml EX-101.LAB 584049
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bgmd-20151231_pre.xml EX-101.PRE 510052
Mailing Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451
Business Address 880 WINTER STREET SUITE 210 WALTHAM MA 02451 781-890-1199
BG Medicine, Inc. (Filer) CIK: 0001407038 (see all company filings)

IRS No.: 043506204 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33827 | Film No.: 161551492
SIC: 2835 In Vitro & In Vivo Diagnostic Substances